Gabriel Schwartz, MSN, NP, explains how mechanisms of action determine the safety of systemic treatments in metastatic colorectal cancer post chemotherapy.

Nurse-led telehealth follow-ups may increase emotional well-being for survivors of ovarian cancer, according to data from a ...

Panelists discuss how specific talquetamab-related side effects like skin peeling, nail changes, and rashes can be ...

JADPRO Live 2025 provides a platform for leaders in oncology advanced practice to share research and best practices with ...

Panelists discuss how patients beginning talquetamab should maintain a positive attitude, prepare thoroughly with educational ...

Panelists discuss how comprehensive patient education materials and manufacturer resources help patients prepare for and ...

Panelists discuss how expectations for treatment outcomes can become more positive over time through experience with multiple ...

Panelists discuss how successful talquetamab treatment requires coordinated care between inpatient and outpatient teams, ...

Panelists discuss how healthcare providers must actively educate local oncologists, emergency departments, and community ...

Panelists discuss how healthcare providers and patients should understand that talquetamab's unique side effects are ...

The FDA has approved a biosimilar of pertuzumab which is indicated for multiple breast cancer settings. The FDA has approved ...

Panelists discuss how effective caregivers should join support groups, maintain detailed records of symptoms and medications, attend all appointments, stay informed about myeloma research, and serve ...